BioSig Technologies (NASDAQ:BSGM) Shares Up 4.6%

Shares of BioSig Technologies, Inc. (NASDAQ:BSGM) shot up 4.6% on Friday . The company traded as high as $0.34 and last traded at $0.34. 20,813 shares were traded during trading, a decline of 96% from the average session volume of 488,961 shares. The stock had previously closed at $0.32.

BioSig Technologies Stock Performance

The business’s 50-day moving average is $0.43 and its 200-day moving average is $0.84.

BioSig Technologies (NASDAQ:BSGM) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.30) earnings per share (EPS) for the quarter. The firm had revenue of $0.01 million during the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in BioSig Technologies stock. Armistice Capital LLC bought a new stake in shares of BioSig Technologies, Inc. (NASDAQ:BSGM) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,600,000 shares of the company’s stock, valued at approximately $2,660,000. Armistice Capital LLC owned approximately 62.36% of BioSig Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 7.16% of the company’s stock.

BioSig Technologies Company Profile

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.